Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Isolation of canine adipose-derived mesenchymal stem cells from falciform tissue obtained via laparoscopic morcellation: A pilot study.

DePompeo CM., Giassetti MI., Elnaggar MM., Oatley JM., Davis WC., Fransson BA.

Animal Study on Face & Skin, published in Vet Surg (2019) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Vet Surg (2019)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
31222769
DOI
10.1111/vsu.13267
Citations
3

Abstract (original English)

Objective To evaluate the feasibility of stem cell isolation from falciform fat harvested via laparoscopic morcellation. Study design Pilot study. Animals Eleven client-owned dogs. Methods Falciform was harvested traditionally via laparotomy and laparoscopically via tissue morcellation. Harvested tissue was processed with a commercially available adipose tissue dissociation kit to obtain a stromal vascular fraction (SVF). Cells were subsequently labeled for CD90, CD45, and CD44 cell surface antigens by using magnetic-activated cell sorting (MACS) and fluorescence-activated cell sorting flow cytometry. CD90 + cells were quantitated, and their viability was assessed with a hemocytometer and a trypan blue exclusion test of cell viability. Results No perioperative complications occurred in dogs undergoing laparoscopic morcellation. Laparoscopically and traditionally harvested samples yielded an average of 0.39 (±0.1) × 10 6 and 0.33 (±0.1) × 10 6 CD90 + cells, respectively, per 10 million SVF cells. CD90 + cell viability after MACS was 89% (±11%) for morcellated and 86% (±7%) for traditionally harvested samples. Neither CD90 + cell quantity nor viability was different between samples obtained via traditional laparotomy vs laparoscopic morcellation (P = .38 and P = .63, respectively). Populations of CD90 + cells isolated with each harvest technique had similar CD44 and CD45 expressi

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAnimalsCells, CulturedDogsFlow CytometryHumansLaparoscopyMesenchymal Stem CellsMorcellationPilot Projects

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research